CytRx Corporation
New reports from CytRx Corporation detailed
Published in Medicine and Law Weekly, August 17th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at CytRx Corporation.
Report 1: CytRx Corporation (NASDAQ:CYTR) announced plans to expand its research and development of therapeutic products based on its novel, orally-administered molecular chaperone amplification technology, including broadening its clinical focus beyond the treatment of diseases related to the central nervous system. CytRx also announced its intent to open a San Diego-based research and development facility in the third quarter of 2007 to provide it with a dedicated laboratory to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Cardiology
Recent findings from Alfred Hospital, Department of Cardiothoracic Surgery highlight research in cardiology - Criminology
New criminology study findings have been reported by R. Hogg and colleagues - Criminology
Report summarizes criminology study findings from R.L. Jackson and co-researchers - Criminology
Reports from Oregon State University advance knowledge in criminology - Criminology
Researchers at Old Dominion University have published new data on criminology - Criminology
Scientists at Temple University publish new data on criminology - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
